The Sunshine Act [available for consultation here] and its implementing royal decree [available for consultation here] require pharmaceutical and medical devices companies to document and disclose annually on the beTransparent platform [available here] premiums and benefits granted, as from 1 January 2017,  directly or indirectly to healthcare professionals (HCPs), healthcare organisations (HCOs) and patient organisations (POs).